Physician

Daniel S Temeles, M.D.

According to 2025 Medicare claims, Daniel Temeles, M.D. (NPI: 1699741629) practices medical oncology in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Bedford, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24523-1401.

Temeles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 237 traditional Medicare patients, billed 91,154 HCPCS/CPT codes, and received $1,420,326 in Medicare payments. The top billing code was 99212 (Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more). Part D data shows 803 prescription claims across 118 beneficiaries totaling $352,457 in drug costs, led by Xarelto (Rivaroxaban). 2023 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $545,683 to $1,420,326. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $574,089 and ending at $352,457. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,347 and ending at $993.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	335	54,971	$545,683
2016	290	47,098	$499,528
2017	329	45,928	$732,443
2018	271	51,131	$569,769
2019	255	70,829	$709,072
2020	241	74,315	$1,016,584
2021	207	72,007	$805,221
2022	197	60,126	$781,226
2023	203	75,872	$874,585
2024	237	91,154	$1,420,326

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	1,168	$574,089
2016	136	1,183	$589,660
2017	156	1,360	$808,456
2018	129	1,072	$365,396
2019	122	932	$47,549
2020	109	862	$229,611
2021	111	772	$279,459
2022	94	741	$198,930
2023	101	714	$310,731
2024	118	803	$352,457

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$1,954
2016	N/R	17	$1,602
2017	N/R	47	$9,983
2018	N/R	47	$9,623
2019	N/R	52	$7,140
2020	N/R	17	$564
2021	N/R	23	$2,894
2022	N/R	43	$2,399
2023	N/R	11	$169
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	152	395	$36
82728	Ferritin (blood protein) level	52	105	$13
80053	Blood test, comprehensive group of blood chemicals	92	266	$10
36415	Insertion of needle into vein for collection of blood sample	110	247	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	153	699	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	18	1,020	$18,610
Oxycodone Hcl	Oxycodone Hcl	40	518	$1,138
Hydroxyurea	Hydroxyurea	49	4,110	$1,066
Anagrelide Hcl	Anagrelide Hcl	11	330	$888
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	535	$671

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Daniel S. Temeles, M.D.?

Tedicare shows public-source Medicare data for Daniel S. Temeles, M.D. (NPI 1699741629), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel S. Temeles, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel S. Temeles, M.D.?

Daniel S. Temeles, M.D. is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does Daniel S. Temeles, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.